EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug Regimen for Patients after a Pneumonectomy

Noheul Kim, Ronny Priefer

Journal of Respiration · 2021

DOI: 10.3390/jor1020013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Respiration, 2021. Verfasst von Noheul Kim und 1 weiteren Autor:innen. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumonectomy is an entire lung removal and is indicated for both malignant and benign diseases. Due to its invasiveness and postoperative complications, pneumonectomy is still associated with high mortality and morbidity. Appropriate postoperative management is crucial in pneumonectomy patients to improve quality of life and overall survival rates. Diverse drug regimens are under development to be used in adjuvant chemotherapy or to improve respiratory health after a pneumonectomy. The most common causes for a pneumonectomy are non-small cell lung cancer, malignant pleural mesothelioma, and tuberculosis; thus, an appropriate drug regimen is necessary. The uncommon incidence of pneumonectomy cases remains the major obstacle in studies of postoperative drug regimens. As the majority of current studies include post-lobectomy and post-segmentectomy patients, it is highly recommended that further research of postoperative drug regimens be focused on post-pneumonectomy patients.

Zitieren

APA

Kim, N., & Priefer, R. (2021). Drug Regimen for Patients after a Pneumonectomy. Journal of Respiration. https://doi.org/10.3390/jor1020013

Vancouver

Kim N, Priefer R. Drug Regimen for Patients after a Pneumonectomy. Journal of Respiration. 2021. doi:10.3390/jor1020013

BibTeX
@article{Kim2021,
  author = {Kim, Noheul and Priefer, Ronny},
  title = {Drug Regimen for Patients after a Pneumonectomy},
  journal = {Journal of Respiration},
  year = {2021},
  doi = {10.3390/jor1020013}
}
Kostenlos starten →